Rubicon Research Limited — Important, 02-06-2026: Updates
02-06-2026 | 06:42 pm
02-06-2026 | 06:42 pm
Rubicon Research reported strong Q4 FY26 results with revenue up 44% YoY to ₹514 Cr and PAT up 112% YoY. The company acquired Arinna Lifesciences for ₹200 Cr to bolster its CNS platform in India. Pithampur facility expected to ramp up in CY27.
No comments yet. Be the first to comment!
